LCompany · Foodtech & Agtech
LEV2050
LEV2050 is a Spanish industrial microbiology company that isolates, develops and produces customised microorganisms (yeasts, bacteria, fungi) plus patented LEV2050® bioreactors and culture media for the agri-food industry. Its core market is winemaking — around 170 wineries across Spain, Portugal, France, Italy, Germany, Argentina and Chile — with expansion into brewing, bakery, probiotics/postbiotics, bioactive peptides, biofertilisation and by-product valorisation. It maintains a strain bank of ~16,000 yeasts and 6,000+ bacteria, and in March 2024 Stellum Food&Tech and Inveready Biotech IV took a 25% stake to fund growth. It is headquartered in Mutilva/Aizoain, Navarra.
Founded
2010
Founders
1
News
3
Rounds
0
Investors
3
SectorsBiotech, Industrial Microbiology, Foodtech & Agtech, Wine & Oenology, Deeptech
Start-up MapFoodtech & Agtech › Food ingredients & manufacturing
Profile updated 23 Aug 2026
Founders
D
David García Yoldi
Founder & CEO
Global models
No comparables on record yet.
Investors 3
Funding rounds
No announced rounds on record.
News & media 3
| Published | Article |
|---|---|
| 2026-01-19 |
La navarra Lev2050 gana capacidad tras ampliar sus instalaciones con una nueva nave ↗
Navarra Capital
|
| 2025-12-04 |
VA Filtration and LEV2050 Exclusive North American Distribution Agreement ↗
Wine Industry Advisor
|
| 2024-03-27 |
Stellum Capital and Inveready acquire minority stake in LEV 2050 ↗
Real Deals
|


